We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

PamGene Enters Co-Marketing Agreement with Invitrogen in Nuclear Hormone Receptor Drug Discovery

News   Jan 17, 2008

 
PamGene Enters Co-Marketing Agreement with Invitrogen in Nuclear Hormone Receptor Drug Discovery
 
 
 

RELATED ARTICLES

New Open-source Solution for the Analysis of High Content Screening Data

News

A new open-source solution for the analysis of high content screening (HCS) data in biomedical research, has been released.

READ MORE

Capturing Cancer Cells Using a Novel Microfluidic Chip

News

Instead of searching for a needle in a haystack, what if you were able to sweep the entire haystack to one side, leaving only the needle behind? That's the strategy researchers followed in developing a new microfluidic device that separates elusive circulating tumor cells (CTCs) from a sample of whole blood.

READ MORE

Organ Chip Facilitates Human Gut Microbiome Studies

News

The anaerobic human Intestine chip supports complex gut microbiome under low oxygen, enabling direct investigations of health and disease-related human-microbiome interactions.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE